Mrđenović, S., Zhang, Y., Wang, R., Yin, L., Chia Yi Chu, G., Yin, L. ... Chung, L. W. K. (2019). Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer, 125. (13), 2222-2232. doi: 10.1002/cncr.32033
Mrđenović, Stefan, et al. "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer, vol. 125, br. 13, 2019, str. 2222-2232. https://doi.org/10.1002/cncr.32033
Mrđenović, Stefan, Yi Zhang, Ruoxiang Wang, Lijuan Yin, Gina Chia Yi Chu, Liyuan Yin, Michael Lewis, Marija Heffer, Haiyen E. Zhau i Leland W. K. Chung. "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer 125, br. 13 (2019): 2222-2232. https://doi.org/10.1002/cncr.32033
Mrđenović, S., et al. (2019) 'Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate', Cancer, 125(13), str. 2222-2232. doi: 10.1002/cncr.32033
Mrđenović S, Zhang Y, Wang R, Yin L, Chia Yi Chu G, Yin L, i sur.. Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer [Internet]. 2019. [pristupljeno 27.10.2024.];125(13):2222-2232. doi: 10.1002/cncr.32033
S. Mrđenović, et al., "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate", Cancer, vol. 125, br. 13, str. 2222-2232, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:239:300171. [Citirano: 27.10.2024.]